🇺🇸 FDA
Patent

US 7531172

Methods of treating diseases with a VEGF antagonist

granted A61KA61K38/179A61P

Quick answer

US patent 7531172 (Methods of treating diseases with a VEGF antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/179, A61P, A61P11/00, A61P3/10